Protagonist Therapeutics (PTGX) Q2 2025 Earnings

6MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.6
0.26
1.12
1.98

Details

Expected EPS
-0.20346
Actual EPS
-0.19
Surprise EPS
0.01
Surprise Percent
+6.62%

Description

Protagonist Therapeutics (PTGX) has reported earnings of -0.19 per share for Q2 2025.

0 Comments

Share your thoughts